Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid TumorsElliott J. Brea, Eric L. Smith, Simon Baldacci et al.|Cancer Immunology Research|2025Cited by 4
Data from Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid TumorsElliott J. Brea, Eric L. Smith, Simon Baldacci et al.|Unknown|2025Cited by 0
Figure_S1 from Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid TumorsElliott J. Brea, Eric L. Smith, Simon Baldacci et al.|Unknown|2025Cited by 0
Figure_S3 from Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid TumorsElliott J. Brea, Eric L. Smith, Simon Baldacci et al.|Unknown|2025Cited by 0
Figure_S2 from Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid TumorsElliott J. Brea, Eric L. Smith, Simon Baldacci et al.|Unknown|2025Cited by 0